<DOC>
	<DOCNO>NCT00249366</DOCNO>
	<brief_summary>The purpose study test tolerable effective lorazepam use treat alcohol withdrawal hospital patient risk alcohol withdrawal .</brief_summary>
	<brief_title>Treatment Alcohol Withdrawal Hospital Patients</brief_title>
	<detailed_description>Studies show symptom-triggered dosing best treatment alcohol withdrawal patient chemical dependence unit without illness . On general medical hospital ward , withdrawal may affect comorbid medical illness . A clinical trial undertaken determine whether difference symptom-triggered ( ST ) fixed-schedule ( FS ) dose lorazepam patient hospitalize general medical ward University medical center . Subjects assessed nurse Revised Clinical Institute Withdrawal Assessment Alcohol ( CIWA-Ar ) scale . Subjects ST arm receive lorazepam dos base CIWA-Ar score . Subjects FS arm receive scheduled lorazepam taper 4 day .</detailed_description>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Alcohol dependence ( base criterion Diagnostic Statistical Manual Mental Disorders , 4th Edition ) Daily alcohol use least seven consecutive day last use 72 hour prior enrollment Patients General Internal Medicine service Unable give inform consent Chronically maintain prescription sedativehypnotics</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Alcohol withdrawal</keyword>
	<keyword>Symptom-triggered therapy</keyword>
	<keyword>Fixed-schedule therapy</keyword>
	<keyword>CIWA-Ar</keyword>
	<keyword>Lorazepam ( drug )</keyword>
</DOC>